Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Improvement in indices of cellular protection after psychological treatment for social anxiety disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A large-scale genomic investigation of susceptibility to infection and its association with mental disorders in the Danish population

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic risk scores for major psychiatric disorders and the risk of postpartum psychiatric disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Reduced neonatal brain-derived neurotrophic factor is associated with autism spectrum disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  • I A Reddy
  • J A Pino
  • P Weikop
  • N Osses
  • G Sørensen
  • T Bering
  • C Valle
  • R J Bluett
  • K Erreger
  • G Wortwein
  • J G Reyes
  • D Graham
  • G D Stanwood
  • T A Hackett
  • S Patel
  • A Fink-Jensen
  • G E Torres
  • A Galli
View graph of relations

Agonism of the glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) has been effective at treating aspects of addictive behavior for a number of abused substances, including cocaine. However, the molecular mechanisms and brain circuits underlying the therapeutic effects of GLP-1R signaling on cocaine actions remain elusive. Recent evidence has revealed that endogenous signaling at the GLP-1R within the forebrain lateral septum (LS) acts to reduce cocaine-induced locomotion and cocaine conditioned place preference, both considered dopamine (DA)-associated behaviors. DA terminals project from the ventral tegmental area to the LS and express the DA transporter (DAT). Cocaine acts by altering DA bioavailability by targeting the DAT. Therefore, GLP-1R signaling might exert effects on DAT to account for its regulation of cocaine-induced behaviors. We show that the GLP-1R is highly expressed within the LS. GLP-1, in LS slices, significantly enhances DAT surface expression and DAT function. Exenatide (Ex-4), a long-lasting synthetic analog of GLP-1 abolished cocaine-induced elevation of DA. Interestingly, acute administration of Ex-4 reduces septal expression of the retrograde messenger 2-arachidonylglycerol (2-AG), as well as a product of its presynaptic degradation, arachidonic acid (AA). Notably, AA reduces septal DAT function pointing to AA as a novel regulator of central DA homeostasis. We further show that AA oxidation product γ-ketoaldehyde (γ-KA) forms adducts with the DAT and reduces DAT plasma membrane expression and function. These results support a mechanism in which postsynaptic septal GLP-1R activation regulates 2-AG levels to alter presynaptic DA homeostasis and cocaine actions through AA.

Original languageEnglish
JournalTranslational psychiatry
Volume6
Pages (from-to)e809
ISSN2158-3188
DOIs
Publication statusPublished - 17 May 2016

    Research areas

  • Animals, Arachidonic Acid, Arachidonic Acids, Cocaine, Dopamine, Dopamine Plasma Membrane Transport Proteins, Dopamine Uptake Inhibitors, Endocannabinoids, Glucagon-Like Peptide-1 Receptor, Glycerides, Homeostasis, Incretins, Mice, Microdialysis, Peptides, Proto-Oncogene Proteins c-fos, Septal Nuclei, Venoms, Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural

ID: 52615619